Recommendations | Population | Grade strength | Quality of evidence (Average) | Quality of evidence | Key references |
---|---|---|---|---|---|
i. We strongly recommend easy access to psychosocial support to improve Quality of life (QoL) | |||||
A multidisciplinary approach in treating EB improves QoL for individuals with EB • Psychological support and close monitoring of EB improves QoL. • They facilitate participation in social activities. • Patients with all types of EB including EBS report a great impairment in QoL due to restrictions in physical and social activities. | ✓ Adults, children (n = 12/185) EBS; JEB; DDEB; RDEB; KS Unclear if adults, children or both (n = 43/134) EBS; JEB; DDEB; RDEB; Adults, children (n = 120/248) EBS; JEB; DDEB; RDEB Review of inherited & autoimmune blistering diseases | B | 2++ | 1- 2+ 2+ 2- 1- | [29] [30] [31] [28] [32] |
ii. We strongly recommend psychosocial support to improve well-being | |||||
To promote self-efficacy and support around body image to aid psychological well-being • Having access to knowledge and resources about EB can help people have a greater role in managing their EB. This self-management can help improve well-being. • Improved self-efficacy and locus of control, as well as support around body-image could help to develop a more positive sense of well-being. For support during transition periods in life (school transitions, transition into adulthood) • Communication and education about EB to improve people’s understanding. • Support from families, EB healthcare professionals and DEBRA. | Review of inherited &autoimmune blistering diseases Adults (n = 87) RDEB, DEB, EBS Children 10–14 years old (n = 11) EBS (autosomal recessive) Young male adults (aged 21–35 years) with RDEB (n = 5) and EBS (n = 2) Observational report | C | 2+ | 1- 2+ 2+ 4 4 | [32] [33] [34] [35] [36] |
iii. We strongly recommend gaining access to psychosocial support for the whole family | |||||
People diagnosed with EB should be referred for psychosocial support as early as possible in childhood or in adulthood, if the person with EB wishes • To support the family unit. Encourage supportive network for the family, for example: • Education about EB for others • Provide access to DEBRA (or other EB support groups) | ✓ Children (n = 11/82) EBS; JEB; DDEB; RDEB Children (n = 16) JEB Adult (n = 1) RDEB | C | 2- | 2- 2- 4 | [37] [38] [39]α |
iv. We recommend psychosocial support to help with pain | |||||
Pain is present for most children and adults with EB (all types) with profound psychosocial impact: • Activity related pain can significantly affect psychosocial well-being and QoL (e.g. fear of/actual pain restricting social activities, affecting relationships with family and friends). • Treatment related pain can make managing EB harder and link to procedural anxiety. Adequate holistic pain management is essential as a focus for helping people with EB: • Following pain guidelines. • Offering approaches to help people with EB cope emotionally. • Help with managing the impact of pain and the interlinked cycle of pain and psychosocial challenges. | Adults, children(n = 374) EBS, JEB, DDEB, RDEB Adults (n = 6) JEB, DDEB Children; (n = 11) EBS, JEB, DDEB, RDEB, Adults (n = 30) children (n = 27) EBS Children/families (n = 70) type of EB unclear Adults (n = 43) EBS, JEB, DDED, RDEB Unclear if adult/child (n = 40) EBS, JEB, DDEB, RDEB Best practice guideline Children (n = 11) EBS, JEB, DDEB, RDEB Adult (n = 1) RDEB | C | 2- | 2+ 2- 2- 2- 2- 2+ 2+ ⇒ 2+ 3 | [3] [40] [37] [42] [41] [30] [44] [7]α [17] [43] |
v. We strongly recommend psychosocial support to help cope with living with EB | |||||
People with EB need support to cope with EB, and their ways of coping need to be supported by others: participation in social life needs to be supported • Such as at school, the community, friendships, employment. • Aid access to supportive networks. • Public education campaigns to help those around them to understand EB and their needs. Promote a sense of self-management of their EB • This can help bring a sense of control over certain aspects of the disease/treatment and pain. Build social skills and communication • Help in learning how to communicate about EB to others and within the family unit. | ✓ Children (n = 27) DDEB; (n = 28) RDEB Children 10–14 years old (n = 11) EBS (autosomal recessive) Children (n = 11/82) EBS; JEB; DDEB; RDEB Children (n = 24) EBS; JEB; DDEB; RDEB | C | 2- | 2+ 2+ 2- 2- | [45] [34] [37] [46] |
vi. We strongly recommend psychosocial support from a multidisciplinary Health Care Team | |||||
Encourage access to, and a collaborative ‘working together’ relationship with, an expert multi-disciplinary team of professionals. • Facilitate access to multidisciplinary professional support for medical and psychosocial care across the lifespan. • At both specialist centres and community services | ✓ Adults, children (n = 15) RDEB Children (n = 21) EBS; JEB; DDEB; RDEB Children (n = 11/82) EBS; JEB; DDEB; RDEB HCPs (n = 33) 30 stakeholders (HCPs, and 9 with EB RDEB, DDEB, EBS) Adults (n = 6) JEB, DDEB Children and Adults (n = 20) EBS, JEB, DEB Children (n = 16) JEB Children (n = 20) EBS, JEB, RDEB | C | 2- | 1- 2+ 2+ 2+ 2- 2- 2- 2- 2- 2+ | [29] [48] [51] [17] [46] [49] [40] [38] [48] [47] |
Key: EB: Epidermolysis Bullosa; RDEB: Recessive Dystrophic Epidermolysis Bullosa; JEB: Junctional Epidermolysis Bullosa; DDEB: Dominant Dystrophic Epidermolysis Bullosa; EBS: Epidermolysis Bullosa Simplex EBS-I: Localised form of EBS; KS Kindler Syndrome; QoL: quality of life; n: number of; α: gray literature; ⇒this is an EB guideline | |||||
Grades | Descriptions in accordance to SIGN [22] | ||||
B | A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ | ||||
C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ | ||||
Ratings Descriptions in accordance to SIGN [22] | |||||
1- | Meta-analyses, systematic reviews, or RCTs with a high risk of bias | ||||
2++ | High quality case control or cohort studies with a very low risk of confounding or bias and a high probability that the relationship is causal | ||||
2+ | Well conducted case control or cohort studies with a low risk of confounding or bias and a moderate probability that the relationship is causal | ||||
2- | Case control or cohort studies with a high risk of confounding or bias and a significant risk | ||||
3 | Non-analytic studies, e.g. case reports, case series | ||||
4 | Expert opinion | ||||
✔ Recommended best practice based on the clinical experience of the guideline development group [22] |